Literature DB >> 23747774

Cardiotonic modulation in heart failure: insights from traditional Chinese medicine.

W H Wilson Tang1, Yanming Huang2.   

Abstract

Entities:  

Keywords:  chronic heart failure; controlled clinical trial; qili qiangxin capsules

Mesh：

Substances：

Year:  2013        PMID： 23747774      PMCID： PMC4024708          DOI： 10.1016/j.jacc.2013.05.028

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  13 in total

1.  The thinking on TCM differential treatment of congestive heart failure.

Authors:  D Liang; M Zhang
Journal:  J Tradit Chin Med       Date:  2000-03       Impact factor: 0.848

2.  Qiliqiangxin inhibits the development of cardiac hypertrophy, remodeling, and dysfunction during 4 weeks of pressure overload in mice.

Authors:  Yunzeng Zou; Li Lin; Yong Ye; Jianming Wei; Ning Zhou; Yanyan Liang; Hui Gong; Lei Li; Jian Wu; Yunbo Li; Zhenhua Jia; Yiling Wu; Jingmin Zhou; Junbo Ge
Journal:  J Cardiovasc Pharmacol       Date:  2012-03       Impact factor: 3.105

3.  Qiliqiangxin improves cardiac function in spontaneously hypertensive rats through the inhibition of cardiac chymase.

Authors:  Wei Liu; Junjun Chen; Tengfei Xu; Wendan Tian; Yue Li; Zhiyi Zhang; Weimin Li
Journal:  Am J Hypertens       Date:  2011-11-17       Impact factor: 2.689

4.  A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure.

Authors:  Xinli Li; Jian Zhang; Jun Huang; Aiqun Ma; Jiefu Yang; Weimin Li; Zonggui Wu; Chen Yao; Yuhui Zhang; Wenming Yao; Boli Zhang; Runlin Gao
Journal:  J Am Coll Cardiol       Date:  2013-06-07       Impact factor: 24.094

Review 5.  Use of herbal products and potential interactions in patients with cardiovascular diseases.

Authors:  Ara Tachjian; Viqar Maria; Arshad Jahangir
Journal:  J Am Coll Cardiol       Date:  2010-02-09       Impact factor: 24.094

6.  Hawthorn Extract Randomized Blinded Chronic Heart Failure (HERB CHF) trial.

Authors:  Suzanna M Zick; Bonnie Motyka Vautaw; Brenda Gillespie; Keith D Aaronson
Journal:  Eur J Heart Fail       Date:  2009-10       Impact factor: 15.534

7.  Low-dose enoximone therapy in pre-transplant patients: hemodynamic, echocardiographic, and neurohumoral findings.

Authors:  J W Park; R Heinzler; J H Wirtz; M Fieten-Rumswinkel; P Braun; E May; R Hetzer; K W Heinrich
Journal:  Z Kardiol       Date:  1994

Review 8.  Hawthorn extract for treating chronic heart failure.

Authors:  M H Pittler; R Guo; E Ernst
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

9.  Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials.

Authors:  Marco Metra; Eric Eichhorn; William T Abraham; Jennifer Linseman; Michael Böhm; Ramon Corbalan; David DeMets; Teresa De Marco; Uri Elkayam; Michael Gerber; Michel Komajda; Peter Liu; Vyacheslev Mareev; Sergio V Perrone; Philip Poole-Wilson; Ellen Roecker; Jennifer Stewart; Karl Swedberg; Michal Tendera; Brian Wiens; Michael R Bristow
Journal:  Eur Heart J       Date:  2009-12       Impact factor: 29.983

10.  A metabolomics-based strategy for the quality control of traditional chinese medicine: shengmai injection as a case study.

Authors:  Xiaodong Li; Huiyuan Chen; Wei Jia; Guoxiang Xie
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-20       Impact factor: 2.629
View more
  23 in total

1.  Qiliqiangxin attenuates isoproterenol-induced cardiac remodeling in mice.

Authors:  Jialiang Zhang; Mengyuan Huang; Shutong Shen; Xiaoting Wu; Xiaodong Wu; Ping Lv; Haifeng Zhang; Hui Wang; Xinli Li
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

2.  Qiliqiangxin improves cardiac function and attenuates cardiac remodelling in doxorubicin-induced heart failure rats.

Authors:  Xutao Sun; Guozhen Chen; Ying Xie; Deyou Jiang; Jieru Han; Fei Chen; Yunjia Song
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

3.  Oral Chinese Herbal Medicine for Heart Failure with Preserved Ejection Fraction: A Meta-Analysis.

Authors:  Jun Mei; Hao Xu; Feng-Qin Xu; Jian-Qing Ju
Journal:  Chin J Integr Med       Date:  2019-05-24       Impact factor: 1.978

4.  Cardioprotective effects of Qishen Granule () on sarcoplasmic reticulum Ca2+ handling in heart failure rats.

Authors:  Ling-Hui Lu; Chun Li; Qi-Yan Wang; Qian Zhang; Yi Zhang; Hui Meng; Yong Wang; Wei Wang
Journal:  Chin J Integr Med       Date:  2017-05-11       Impact factor: 1.978

5.  Safflower extract inhibiting apoptosis by inducing autophagy in myocardium derived H9C2 cell.

Authors:  Zhisheng Jia; Yancai Liu; Huailing Su; Ming Li; Min Zhang; Ye Zhu; Tenjiao Li; Youbo Fang; Shimin Liang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

6.  Traditional Chinese Medication Qiliqiangxin attenuates cardiac remodeling after acute myocardial infarction in mice.

Authors:  Lichan Tao; Sutong Shen; Siyi Fu; Hongyi Fang; Xiuzhi Wang; Saumya Das; Joost P G Sluijter; Anthony Rosenzweig; Yonglan Zhou; Xiangqing Kong; Junjie Xiao; Xinli Li
Journal:  Sci Rep       Date:  2015-02-11       Impact factor: 4.379

Review 7.  Clinical effects of a standardized Chinese herbal remedy, Qili Qiangxin, as an adjuvant treatment in heart failure: systematic review and meta-analysis.

Authors:  Jin Sun; Kang Zhang; Wen-Jing Xiong; Guo-Yan Yang; Yun-Jiao Zhang; Cong-Cong Wang; Lily Lai; Mei Han; Jun Ren; George Lewith; Jian-Ping Liu
Journal:  BMC Complement Altern Med       Date:  2016-07-11       Impact factor: 3.659

8.  Xinfuli Granule improves post-myocardial infarction ventricular remodeling and myocardial fibrosis in rats by regulating TGF-β/Smads signaling pathway.

Authors:  Jie Ma; Zhi-Yuan Li; Xiao-Peng Liang; Cai-Xia Guo; Pei-Pei Lu; Li-Hong Ma
Journal:  J Geriatr Cardiol       Date:  2017-05       Impact factor: 3.327

9.  Efficacy and safety of electroacupuncture in acute decompensated heart failure: a study protocol for a randomized, patient- and assessor-blinded, sham controlled trial.

Authors:  Jungtae Leem; Seung Min Kathy Lee; Jun Hyeong Park; Suji Lee; Hyemoon Chung; Jung Myung Lee; Weon Kim; Sanghoon Lee; Jong Shin Woo
Journal:  BMC Complement Altern Med       Date:  2017-07-11       Impact factor: 3.659

Review 10.  The Clinical Efficacy of Yindanxinnaotong Soft Capsule in the Treatment of Stroke and Angina Pectoris: A Meta-Analysis.

Authors:  Long Cheng; Yue Liu; Xiao-Bo Sun
Journal:  Evid Based Complement Alternat Med       Date:  2017-04-30       Impact factor: 2.629
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.